Xiangbin Meng

1.3k total citations · 1 hit paper
41 papers, 494 citations indexed

About

Xiangbin Meng is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Xiangbin Meng has authored 41 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 13 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Epidemiology. Recurrent topics in Xiangbin Meng's work include Cardiovascular Function and Risk Factors (7 papers), Cardiomyopathy and Myosin Studies (7 papers) and Thyroid Disorders and Treatments (7 papers). Xiangbin Meng is often cited by papers focused on Cardiovascular Function and Risk Factors (7 papers), Cardiomyopathy and Myosin Studies (7 papers) and Thyroid Disorders and Treatments (7 papers). Xiangbin Meng collaborates with scholars based in China, United States and Romania. Xiangbin Meng's co-authors include Yi‐Da Tang, Chunli Shao, Wenyao Wang, Kuo Zhang, Jie Yang, Jun Gao, Yitian Zheng, Jian Tao, Hua‐Hua Chang and Chen Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Xiangbin Meng

35 papers receiving 488 citations

Hit Papers

The Impact of the Stress Hyperglycemia Ratio on Short-ter... 2022 2026 2023 2024 2022 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Impact of the Stress Hyperglycemia Ratio on Short-term and Long-term Poor Prognosis in Patients With Acute Coronary Syndrome: Insight From a Large Cohort Study in Asia
    2022 131 citations Jie Yang, Yitian Zheng et al. Diabetes Care profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangbin Meng China 11 217 209 129 57 45 41 494
Marianna Török Hungary 12 50 0.2× 281 1.3× 69 0.5× 46 0.8× 43 1.0× 34 546
Manuel Varela Spain 11 75 0.3× 150 0.7× 50 0.4× 50 0.9× 32 0.7× 30 371
Alec Saunders United Kingdom 5 37 0.2× 94 0.4× 44 0.3× 61 1.1× 18 0.4× 7 500
Nirav Patel United States 11 30 0.1× 174 0.8× 69 0.5× 91 1.6× 29 0.6× 47 451
Arnaldo Moura Neto Brazil 13 307 1.4× 21 0.1× 52 0.4× 69 1.2× 34 0.8× 44 513
Soroush Safaei New Zealand 9 31 0.1× 61 0.3× 56 0.4× 50 0.9× 42 0.9× 29 342
Yingxian Sun China 12 99 0.5× 208 1.0× 147 1.1× 41 0.7× 25 0.6× 32 444
Tao Shan China 11 45 0.2× 68 0.3× 37 0.3× 41 0.7× 31 0.7× 37 357
Stefan Englert Germany 16 24 0.1× 21 0.1× 97 0.8× 85 1.5× 23 0.5× 34 721

Countries citing papers authored by Xiangbin Meng

Since Specialization
Citations

This map shows the geographic impact of Xiangbin Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangbin Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangbin Meng more than expected).

Fields of papers citing papers by Xiangbin Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangbin Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangbin Meng. The network helps show where Xiangbin Meng may publish in the future.

Co-authorship network of co-authors of Xiangbin Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangbin Meng. A scholar is included among the top collaborators of Xiangbin Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangbin Meng. Xiangbin Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meng, Xiangbin, Xiangyu Yan, Jiaming Ji, et al.. (2024). Revolutionizing Health Care: The Transformative Impact of Large Language Models in Medicine. Journal of Medical Internet Research. 27. e59069–e59069. 22 indexed citations
2.
Liu, Da, Mingqi Zheng, Mei Wei, et al.. (2024). GPR30 Selective Agonist G1 Exhibits Antiobesity Effects and Promotes Insulin Resistance and Gluconeogenesis in Postmenopausal Mice Fed a High‐Fat Diet. SHILAP Revista de lepidopterología. 2024(1). 5513473–5513473. 1 indexed citations
3.
Wang, Wenyao, Xuan Zhang, Jun Gao, et al.. (2024). Effects of levothyroxine in subclinical hypothyroidism and heart failure with reduced ejection fraction: An open-label randomized trial. Cell Reports Medicine. 5(4). 101473–101473. 4 indexed citations
4.
Li, Chen, Chuangshi Wang, Yitian Zheng, et al.. (2023). Changes in Drug Clinical Trials of Thyroid Diseases in China, 2009–2022. Drug Design Development and Therapy. Volume 17. 2315–2324. 3 indexed citations
5.
Du, Leilei, Jingjing Song, Yupeng Liu, et al.. (2023). Association of triglyceride-glucose index with atherosclerotic cardiovascular disease and mortality among familial hypercholesterolemia patients. Diabetology & Metabolic Syndrome. 15(1). 39–39. 20 indexed citations
6.
Meng, Xiangbin, Jun Gao, Kuo Zhang, et al.. (2023). The triglyceride-glucose index as a potential protective factor for hypertrophic obstructive cardiomyopathy without diabetes: evidence from a two-center study. Diabetology & Metabolic Syndrome. 15(1). 1 indexed citations
7.
Yang, Jie, Hongyi Tang, Zexuan Guo, et al.. (2023). High triglyceride-glucose (TyG) index is associated with poor prognosis of heart failure with preserved ejection fraction. Cardiovascular Diabetology. 22(1). 263–263. 54 indexed citations
8.
Du, Leilei, Xiangbin Meng, Jun Gao, et al.. (2023). Association of dietary inflammatory index with helicobacter pylori infection and mortality among US population. Journal of Translational Medicine. 21(1). 538–538. 12 indexed citations
9.
Zheng, Yitian, Qi Yu, Samuel Seery, et al.. (2022). Elevated HsCRP in Chronic Obstructive Pulmonary Disease: A Prospective Study of Long-Term Outcomes After Percutaneous Coronary Intervention. International Journal of COPD. Volume 17. 2517–2528.
10.
11.
Yang, Jie, Yitian Zheng, Chen Li, et al.. (2022). The Impact of the Stress Hyperglycemia Ratio on Short-term and Long-term Poor Prognosis in Patients With Acute Coronary Syndrome: Insight From a Large Cohort Study in Asia. Diabetes Care. 45(4). 947–956. 131 indexed citations breakdown →
12.
Zheng, Yitian, Yu Qi, Samuel Seery, et al.. (2022). Long-Term Outcomes for Chinese COPD Patients After PCI: A Propensity Score Matched, Double-Cohort Study. Frontiers in Cardiovascular Medicine. 9. 827635–827635. 1 indexed citations
13.
14.
Meng, Xiangbin, Jun Gao, Kuo Zhang, et al.. (2022). Hypertrophic Obstructive Cardiomyopathy: Comparison of Outcomes After Myectomy or Alcohol Ablation. Frontiers in Cardiovascular Medicine. 9. 755376–755376. 8 indexed citations
15.
Meng, Xiangbin, Zhiyuan Zhang, Kuo Zhang, et al.. (2022). Association Between Thyroid Dysfunction and Incidence of Atrial Fibrillation in Patients With Hypertrophic Obstructive Cardiomyopathy. Frontiers in Endocrinology. 13. 875003–875003.
16.
Liu, Yupeng, Jingjing Song, Wenyao Wang, et al.. (2022). Association of Ejection Fraction with Mortality and Cardiovascular Events in Patients with Coronary Artery Disease. ESC Heart Failure. 9(5). 3461–3468. 7 indexed citations
17.
Yang, Jie, Yitian Zheng, Chen Li, et al.. (2021). The Impact of Subclinical Hyperthyroidism on Cardiovascular Prognosis in Patients Undergoing Percutaneous Coronary Intervention. The Journal of Clinical Endocrinology & Metabolism. 107(4). 986–997. 1 indexed citations
18.
Yang, Jie, Yi‐Da Tang, Yitian Zheng, et al.. (2021). The Impact of the Triglyceride-Glucose Index on Poor Prognosis in NonDiabetic Patients Undergoing Percutaneous Coronary Intervention. Frontiers in Endocrinology. 12. 710240–710240. 42 indexed citations
19.
Meng, Xiangbin, et al.. (2019). Sensorless control for PMSM based on SMC and AFEKF. 38(1). 97–100. 1 indexed citations
20.
Meng, Xiangbin, Wenyao Wang, Kuo Zhang, et al.. (2018). Epicardial adipose tissue volume is associated with non-alcoholic fatty liver disease and cardiovascular risk factors in the general population. Therapeutics and Clinical Risk Management. Volume 14. 1499–1506. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marianna Török Breakdown of academic impact, for papers by Manuel Varela Breakdown of academic impact, for papers by Alec Saunders Breakdown of academic impact, for papers by Nirav Patel Breakdown of academic impact, for papers by Arnaldo Moura Neto Breakdown of academic impact, for papers by Soroush Safaei Breakdown of academic impact, for papers by Yingxian Sun Breakdown of academic impact, for papers by Tao Shan Breakdown of academic impact, for papers by Stefan Englert
Rankless by CCL
2026